Biography

Matt McAviney, MD joined NEA in 2018 and is currently a Partner on the Healthcare team, focused on biopharma investments. Prior to NEA, Matt was a Principal at F-Prime Capital, where he was responsible for closing investments in multiple private biopharma companies. He has also held roles at Oliver Wyman, Robert W. Baird, and JP Morgan. Matt received a BA in Biological Sciences from the University of Chicago, an MD from the University of Illinois, and an MBA from the University of Chicago Booth School of Business.